Heart failure drug shows promise in first human trial
Heart failure patients have weakened hearts, but researchers say an experimental drug used for the first time in humans may repair heart cells and improve heart function.

According to the results of a small phase 1 trial, a single intravenous infusion of the drug cimaglermin was safe and, at high doses, improved heart function for at least three months....

http://www.cbsnews.com/news/heart-failure-drug-shows-promise-in-first-human-trials/
Like
Comment
Share